Answers are grounded in this paper and cite their sources.
Current literature shows strong data for transdermal buprenorphine and promising data for sublingual buprenorphine. With this evidence, buprenorphine could have a more expanded role in managing adult cancer pain.
No takes yet. Share an insight, caveat, or question.
Degnan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: